Clinical Trials Browser

Phase 2 × Triple Negative Breast Neoplasms × dostarlimab × Clear all

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms